Assessment of Elevated Pentraxin 3 Levels in Systemic Sclerosis: Comment on the Article by Shirai et al

Publisher： John Wiley & Sons Inc

E-ISSN： 2326-5205|67|5|1408-1409

ISSN： 2326-5191

Source： ARTHRITIS & RHEUMATOLOGY, Vol.67, Iss.5, 2015-05, pp. : 1408-1409

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Elevated Levels of Pentraxin 3 in Systemic Sclerosis: Associations With Vascular Manifestations and Defective Vasculogenesis

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 2, 2015-02 ,pp. : 498-507

John Wiley & Sons Inc

Access to resources Recommend Favorite

Anti–RNA Polymerase II Antibodies in a US Cohort of Systemic Sclerosis Patients: Comment on the Article by Hamaguchi et al

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 9, 2015-09 ,pp. : 2547-2548

John Wiley & Sons Inc

Access to resources Recommend Favorite

Assessment of the Characteristics of Circulating Follicular Helper T–like Cells in Systemic Lupus Erythematosus: Comment on the Article by Choi et al

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 11, 2015-11 ,pp. : 3094-3094

John Wiley & Sons Inc

Access to resources Recommend Favorite

Is the Measurement of Anti–PM‐1α Antibodies at Least as Important as That of Other Systemic Sclerosis–Specific Antibodies? Comment on the Article by D'Aoust et al

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 66, Iss. 11, 2014-11 ,pp. : 3248-3248

John Wiley & Sons Inc

Access to resources Recommend Favorite

Implications of elevated C‐reactive protein and serum amyloid A levels in IgG4‐related disease: comment on the article by Perugino et al

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 70, Iss. 2, 2018-02 ,pp. : 317-318

John Wiley & Sons Inc

Access to resources Recommend Favorite